Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionMission Wealth Management, Lp
Latest Disclosed Ownership11,559 shares
Latest Disclosed Value $ 1,611,031
Mission Wealth Management, Lp ownership in GILD / Gilead Sciences, Inc.

On May 15, 2026 - Mission Wealth Management, Lp filed a 13F-HR form disclosing ownership of 11,559 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,611,031 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 12,689 shares of Gilead Sciences, Inc.. This represents a change in shares of -8.91% during the quarter.

Mission Wealth Management, Lp has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 11,559 -1,130 -8.91 1,611 3.47 0.0331
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 12,689 -125 -0.98 1,557 9.49 0.0311
2025-11-04 2025-09-30 13F GILEAD SCIENCES COM 375558103 12,814 -64 -0.50 1,422 -0.35 0.0282
2025-08-05 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,878 -32 -0.25 1,428 -1.31 0.0305
2025-04-17 2025-03-31 13F GILEAD SCIENCES COM 375558103 12,910 2,285 21.51 1,447 47.40 0.0355
2025-02-06 2024-12-31 13F GILEAD SCIENCES COM 375558103 10,625 -1,429 -11.85 981 -2.87 0.0229
2024-10-31 2024-09-30 13F GILEAD SCIENCES COM 375558103 12,054 -413 -3.31 1,011 18.13 0.0245
2024-08-05 2024-06-30 13F GILEAD SCIENCES COM 375558103 12,467 13 0.10 855 -6.25 0.0227
2024-04-30 2024-03-31 13F GILEAD SCIENCES COM 375558103 12,454 368 3.04 912 -6.84 0.0240
2024-02-05 2023-12-31 13F GILEAD SCIENCES COM 375558103 12,086 1,367 12.75 979 21.92 0.0318
2023-10-24 2023-09-30 13F GILEAD SCIENCES COM 375558103 10,719 340 3.28 803 0.50 0.0299
2023-08-04 2023-06-30 13F GILEAD SCIENCES COM 375558103 10,379 -7,538 -42.07 800 -46.23 0.0302
2023-04-07 2023-03-31 13F GILEAD SCIENCES COM 375558103 17,917 -4 -0.02 1,487 -3.38 0.0622
2023-02-02 2022-12-31 13F GILEAD SCIENCES COM 375558103 17,921 -2,880 -13.85 1,538 19.88 0.0736
2022-10-12 2022-09-30 13F GILEAD SCIENCES COM 375558103 20,801 1,113 5.65 1,283 5.42 0.0679
2022-07-27 2022-06-30 13F GILEAD SCIENCES COM 375558103 19,688 -2,236 -10.20 1,217 -6.60 0.0640
2022-04-25 2022-03-31 13F GILEAD SCIENCES COM 375558103 21,924 8,302 60.95 1,303 31.75 0.0602
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 13,622 -667 -4.67 989 -0.90 0.0445
2021-11-05 2021-09-30 13F GILEAD SCIENCES COM 375558103 14,289 -2,040 -12.49 998 -11.21 0.0508
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 16,329 -511 -3.03 1,124 3.31 0.0596
2021-05-10 2021-03-31 13F GILEAD SCIENCES COM 375558103 16,840 -2,093 -11.05 1,088 -1.36 0.0631
2021-01-19 2020-12-31 13F GILEAD SCIENCES COM 375558103 18,933 1,020 5.69 1,103 -2.56 0.0690
2020-10-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 17,913 148 0.83 1,132 -17.19 0.0848
2020-08-03 2020-06-30 13F GILEAD SCIENCES COM 375558103 17,765 1,010 6.03 1,367 9.10 0.1179
2020-04-27 2020-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 16,755 -28,723 -63.16 1,253 -57.60 0.1383
2020-04-10 2020-03-31 13F GILEAD SCIENCES COM 375558103 16,755 -28,723 1,253 138,973.6139
2020-01-21 2019-12-31 13F GILEAD SCIENCES COM 375558103 45,478 -2,871 -5.94 2,955 -3.56 0.2841
2019-10-16 2019-09-30 13F GILEAD SCIENCES COM 375558103 48,349 30,707 174.06 3,064 157.05 0.3273
2019-08-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 17,642 -402 -2.23 1,192 1.62 0.1336
2019-05-14 2019-03-31 13F GILEAD SCIENCES COM 375558103 18,044 -87 -0.48 1,173 3.44 0.1362
2019-02-07 2018-12-31 13F GILEAD SCIENCES COM 375558103 18,131 -74 -0.41 1,134 -19.35 0.1478
2018-11-01 2018-09-30 13F GILEAD SCIENCES COM 375558103 18,205 -277 -1.50 1,406 7.41 0.1851
2018-08-08 2018-06-30 13F GILEAD SCIENCES COM 375558103 18,482 379 2.09 1,309 -4.10 0.1932
2018-05-04 2018-03-31 13F GILEAD SCIENCES COM 375558103 18,103 15,318 550.02 1,365 582.50 0.2202
2018-02-09 2017-12-31 13F GILEAD SCIENCES COM 375558103 2,785 -351 -11.19 200 -21.26 0.0343
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 3,136 -788 -20.08 254 -8.63 0.0466
2017-08-11 2017-06-30 13F GILEAD SCIENCES COM 375558103 3,924 57 1.47 278 5.70 0.0528
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 3,867 -758 -16.39 263 -20.54 0.0511
2017-01-27 2016-12-31 13F GILEAD SCIENCES COM 375558103 4,625 736 18.93 331 7.47 0.0659
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 3,889 -30 -0.77 308 -5.81 0.0744
2016-08-03 2016-06-30 13F GILEAD SCIENCES COM 375558103 3,919 -889 -18.49 327 -26.02 0.0869
2016-04-15 2016-03-31 13F GILEAD SCIENCES COM 375558103 4,808 1,183 32.63 442 20.44 0.1190
2016-02-16 2015-12-31 13F GILEAD SCIENCES COM 375558103 3,625 480 15.26 367 18.77 0.1033
2015-10-22 2015-09-30 13F GILEAD SCIENCES COM 375558103 3,145 91 2.98 309 3.00 0.0935
2015-08-11 2015-06-30 13F GILEAD SCIENCES COM 375558103 3,054 3,054 300 0.1026
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-10-15 2020-09-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 n/a n/a n/a
2020-08-03 2020-06-30 13F GILEAD SCIENCES COM Call 400 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-14 2019-03-31 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-07 2018-12-31 13F GILEAD SCIENCES COM Put 7,000 438 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.